scPharmaceuticals Inc (SCPH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

2400 DISTRICT AVENUE BURLINGTON, MA 01803

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company's lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA.

Data as of 2021-10-09 10:31:37 -0400
Market Cap182.461 Million Shares Outstanding27.355 Million Avg 30-day Volume41.278 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-5.54 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.80005 52-week High/Low9.64 / 4.75 Next Earnings Date2021-11-15 Price to Cash FLow (P/CF) -23.0584
Data provided by IEX Cloud
View SEC Filings from SCPH instead.

View recent insider trading info

Funds Holding SCPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SCPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SCHAEFFER LEONARD D

  • Director
16,300 2021-06-08 1

VEITINGER KLAUS R DR

  • Director
16,300 2021-06-08 1

HUDSON FREDERICK M.

  • Director
16,300 2021-06-08 1

KHATTAR JACK A.

  • Director
16,300 2021-06-08 1

BONSTEIN SARA

  • Director
16,300 2021-06-08 1

BAYLOR-HENRY MINNIE

  • Director
16,300 2021-06-08 1

ABRAHAM WILLIAM TOBER

  • Director
16,300 2021-06-08 3

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2021-03-12 1

TUCKER JOHN H PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-25 1

NOKES RACHAEL SEE REMARKS

  • Officer
0 2021-01-25 1

COLEMAN DOROTHY

  • Director
0 2020-06-09 0

AGGER METTE KIRSTINE

  • Director
0 2020-06-09 0

FREEMAN MASON

  • Director
0 2020-06-09 0

SCHWAB ANDREW J.

  • 10% Owner
3,831,474 2020-05-26 0

5AM OPPORTUNITIES I (GP), LLC

5AM OPPORTUNITIES I, L.P.

  • SEE REMARKSSEE REMARKS
578,034 2020-05-26 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED GENESIS GP LLC

  • 10% Owner
4,797,148 2020-05-21 0

RA CAPITAL MANAGEMENT, LLC

RA CAPITAL HEALTHCARE FUND LP

  • 10% Owner
3,247,005 2019-04-11 1

PARMAR KUSH

  • Director
0 2018-06-19 0

IGNELZI TROY A. CHIEF FINANCIAL OFFICER

  • Officer
0 2018-01-17 0

CEESAY ABRAHAM CHIEF OPERATING OFFICER

  • Officer
0 2018-01-17 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ISALY SAMUEL D

  • 10% Owner
3,409,865 2017-11-21 0

SILVERSTEIN JONATHAN

  • Director
No longer subject to file 2017-11-21 0

SUN PHARMACEUTICAL INDUSTRIES LTD

SHANGHVI DILIP S

SUN PHARMA (NETHERLANDS) B.V.

SUN PHARMACEUTICAL INDUSTRIES, INC.

  • 10% Owner
2,167,679 2017-11-21 0

5AM PARTNERS IV, LLC

5AM VENTURES IV, L.P.

5AM CO-INVESTORS IV, L.P.

SCHWAB ANDREW J.

DIEKMAN JOHN D

ROCKLAGE SCOTT M

  • 10% Owner
3,253,437 2017-11-21 0

LUNDBECKFOND INVEST A/S

  • 10% Owner
3,183,986 2017-11-21 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

  • 10% Owner
2,857,143 2017-11-17 0

GANDHI ABHAY

  • Director
0 2017-11-16 0

SUN PHARMACEUTICAL INDUSTRIES, INC.

  • 10% Owner
0 2017-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SCPHARMACEUTICALS INC SCPH 2021-10-15 22:15:04 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 21:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 21:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 20:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 20:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 19:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 19:15:04 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 18:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 18:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 17:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 17:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 16:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 16:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 15:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 15:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 14:45:02 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 14:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 13:45:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 13:15:03 UTC -0.6169 0.6869 250000
SCPHARMACEUTICALS INC SCPH 2021-10-15 12:45:03 UTC -0.6169 0.6869 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments